Request to Join
has invited you to join this group
Anna Lembke, MD, is an associate professor in the department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She is medical director of Stanford Addiction Medicine, program director for the Stanford Addiction Medicine Fellowship, and chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. Dr. Lembke received her BA in Humanities from Yale University and her MD from Stanford University, where she also completed her residency in Psychiatry and fellowship in mood disorders. She is a diplomate of the American Board of Psychiatry and Neurology, and of the American Board of Addiction Medicine. Dr. Lembke has developed multiple teaching programs on drug misuse and addiction therapy. She has held multiple leadership and mentorship positions and received the Stanford’s Chairman’s Award for Clinical Innovation, and the Stanford Departmental Award for Outstanding Teaching. She chaired the Planning Committee for the California Society of Addiction Medicine (CSAM) Annual Addiction Medicine Conference and is the president of the Addiction Medicine Fellowship Directors Association (AMFDA). She has published over 50 peer-reviewed articles, chapters, and commentaries, is author of the bestselling book, Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop (Johns Hopkins University Press, November 2016).
Dr. Nelson is Professor and Chair of the Department of Emergency Medicine and Chief of the Division of Medical Toxicology at Rutgers New Jersey Medical School in Newark, NJ. He completed his residency in emergency medicine at Mount Sinai School of Medicine and a fellowship in medical toxicology at New York University. Dr. Nelson is a member of the Board of Directors of the American Board of Emergency Medicine and a Past-President of the American College of Medical Toxicology. He remains actively involved with CDC, FDA, DHS, and with several professional medical organizations on clincial and public health issues surrounding abused drugs and addiction. Dr. Nelson is an editor of the textbook Goldfrank’s Toxicologic Emergencies (now in its 10th edition) and on the editorial boards of several journals including Annals of Emergency Medicine and Journal of Medical Toxicology. In addition to providing direct clinical care to patient in the ED, he is intimately involved with care provided through the New Jersey Poison Information & Education System. His areas of clinical and scholarly interest include safe medication use, particularly opioids, pain management, emerging drugs of abuse, and medication safety.
Jeanmarie Perrone, MD, FACMT is the Director of the Division of Medical Toxicology and is a Professor of Emergency Medicine at the Perelman School of Medicine at the University of Pennsylvania. She attends clinically caring for patients in the Emergency Department and is a consultant toxicologist for the Philadelphia Poison Center. She has won numerous teaching and mentoring awards for her role with students and residents in emergency medicine and has been inducted into the Penn Medicine Academy of Master Clinicians. Her most recent efforts have focused on addressing the opioid epidemic and educating providers to scale back opioid prescribing and to engage patients with opioid use disorder into treatment from the ED and the hospital. She has lectured nationally and internationally and published in NEJM and JAMA. She has served on several pivotal FDA Drug Safety Advisory Committees identifying efforts to limit the epidemic of prescription drug abuse.
Jianguo Cheng, MD, PhD, is Professor of Anesthesiology and Director of the Cleveland Clinic Multidisciplinary Pain Medicine Fellowship Program. He is immediate Past President of American Academy of Pain Medicine (AAPM) and immediate past Chair of the US Section of World Institute of Pain. He is a member of the US Department of Health and Human Services (HHS) Pain Management Best Practices Inter-agency Task Force (PMTF) to propose updates to best practices and issue recommendations that address gaps or inconsistencies for managing chronic and acute pain. Dr. Cheng serves in the National Academy of Medicine Action Collaborative on Countering the US Opioid Epidemic. Dr. Cheng is also a member of the Centers for Medicare & Medicaid Services (CMS) Expert Work Group (EWG) to develop, specify, and maintain clinical quality measures. As a clinician, Dr. Cheng was recognized by Best Doctors in America (Best Doctors Inc.), 70 Best Pain Management Physicians in the US (Becker's ASC Review), and Top Doctors (International Association of Anesthesiologists). As a physician investigator, Dr. Cheng has directed basic, translational, and clinical investigations of stem cells, opioid tolerance, and chronic pain. His research is supported by research grants from the National Institutes of Health (NIH), the Department of Defense, and other funding agencies. He has published more than 250 articles including investigations on opioid tolerance and neuropathic pain. As an educator, Dr. Cheng has published two textbooks <Fundamentals of Pain Medicine> (Springer-Nature) <Neuropathic Pain: A Case-based Approach to Practical Management> (Oxford University Press) and has given more than 160 lectures/presentations world-wide. He has trained more than 160 clinical pain fellows and postdoctoral research fellows. In addition, Dr. Cheng has played active leadership roles in the Association of University Anesthesiologists (AUA), American Board of Anesthesiology (ABA), American Society of Anesthesiologists (ASA), and American Academy of Regenerative Medicine. He has served as Senior Editor, Associate Editor, and Section Editor for the scientific journals of “Pain Medicine”, “Pain Practice”, and “Pain Physician”. Dr. Cheng was trained in Pain Medicine at Harvard University (Fellowship at Massachusetts General Hospital), Surgery and Anesthesiology at University of Louisville (Residency), Neurology at the Qingdao University, and Neurosciences at the University of Guelph (PhD, Biophysics), University of Manitoba, and University of Alberta.
Alison Rapoport, MD, joined the Division of Infectious Diseases at Cambridge Health Alliance in 2017. She is also an Instructor in Medicine at Harvard Medical School. She completed her infectious diseases fellowship at Beth Israel Deaconess Medical Center and her internal medicine residency and chief resident year at Cambridge Health Alliance. Her research interests focus on the intersections between substance use disorders and infectious diseases.
Dr. Choo joined the Department of Emergency Medicine at OHSU in 2016 as full-time faculty in the Center for Policy & Research in Emergency Medicine. Her research interests include substance use disorders, the effect of state policy on drug use and related outcomes, and the intersection of cannabis and opioid use.
Dr. Andrea Cheville is an Associate Professor of Physical Medicine and Rehabilitation at Mayo Clinic in Rochester, MN. She received her MD degree from Harvard Medical School in 1993 and her MSCE degree from the University of Pennsylvania in 2006. Her areas of interest are lymphedema and cancer rehabilitation and palliative medicine. She is board-certified in Physical Medicine and Rehabilitation, Pain Medicine, and Palliative Care.
Theresa Vettese, MD, FACP is an associate professor of medicine in the Division of General Medicine and Geriatrics, Department of Medicine at Emory University School of Medicine. She spent ten years at Wayne State University School of Medicine in Detroit, where she served as residency program director and division chief of general internal medicine before joining the faculty at Emory University School of Medicine and Grady Memorial Hospital in July of 2015. Dr. Vettese's clinical responsibilities include serving as an internal medicine inpatient ward attending at Grady and previously she also served on the Palliative Care team at Grady. She was recently awarded the Emory Internal Medicine Residency Program Inpatient Teaching Award and the Division Catalyst Award for her work in mentoring junior faculty. In addition, Dr. Vettese serves on the Department of Medicine's faculty development committee and as a member of the steering committee of the Education Community. Her academic interests include skills-training in physician-patient communication, pain management, and addiction medicine.
Daniel P. Alford, MD, MPH is Professor of Medicine, Associate Dean of Continuing Medical Education and Director of the Safe and Competent Opioid Prescribing Education (SCOPE of Pain) program at Boston University School of Medicine. He is Director of the Clinical Addiction Research and Education (CARE) Unit at Boston Medical Center. He is past-president of the Association for Medical Education and Research in Substance Abuse (AMERSA). His clinical, educational and research interests focus on opioid use disorders and safe and competent opioid prescribing for chronic pain.